Literature DB >> 29251290

Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.

Danielle M Fournier1, Angela F Bazzell1, Joyce E Dains1.   

Abstract

PROBLEM IDENTIFICATION: Genetic counseling is vital in helping people at high risk for hereditary breast and ovarian cancer (HBOC) make informed decisions to undergo BRCA testing. Many people, particularly those in rural locations, lack access to these services. This review examines evidence to determine if remotely delivered genetic counseling via telephone or telemedicine is an effective alternative to in-person counseling for people who are at high risk for HBOC.
. LITERATURE SEARCH: A literature review was completed by searching PubMed, SCOPUS, and CINAHL® databases.
. DATA EVALUATION: 151 articles were identified from the search, and 7 were included in the review.
. SYNTHESIS: Patients' BRCA knowledge acquisition, cancer-specific distress, anxiety, depression, and satisfaction with mode of counseling delivery were equivalent between in-person and remotely delivered counseling groups. Genetic testing rates were significantly higher in participants receiving in-person counseling. Remotely delivered genetic counseling was more convenient and less expensive. Mixed outcomes existed regarding counselor-patient communication. 
. IMPLICATIONS FOR PRACTICE: The demand for genetic counseling will grow as advances in cancer genomics reveal genes that may contribute to cancer predisposition. Innovative delivery models are necessary to ensure that all people have access to care.

Entities:  

Keywords:  BRCA; genetic counseling; hereditary breast and ovarian cancer; telegenetics

Mesh:

Year:  2018        PMID: 29251290     DOI: 10.1188/18.ONF.96-105

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  2 in total

Review 1.  Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.

Authors:  Jeanna M McCuaig; Susan Randall Armel; Melanie Care; Alexandra Volenik; Raymond H Kim; Kelly A Metcalfe
Journal:  Cancers (Basel)       Date:  2018-11-13       Impact factor: 6.639

2.  IMPACT webinars: Improving Patient Access to genetic Counselling and Testing using webinars-the Alberta experience with hypertrophic cardiomyopathy.

Authors:  Susan Christian; Julia Tagoe; Lenore Delday; Francois P Bernier; Ruth Kohut; Raechel Ferrier
Journal:  J Community Genet       Date:  2021-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.